Neximmune to present at the 2021 cantor virtual global healthcare conference

Gaithersburg, md., sept. 27, 2021 (globe newswire) -- neximmune, inc. (nasdaq: nexi), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific t cells, today announced that scott carmer, chief executive officer, will present at the 2021 cantor virtual global healthcare conference wednesday, september 29, 2021 at 2:00 pm eastern time.
NEXI Ratings Summary
NEXI Quant Ranking